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Abstract
Background: Preterm brain injury consists primarily of periventricular leukomalacia accompanied by elements of
gray-matter injury, and these injuries are associated with cerebral palsy and cognitive impairments. Inflammation is
believed to be an important contributing factor to these injuries. The aim of this study was to examine the immune
response in a postnatal day (PND) 5 mouse model of preterm brain injury induced by hypoxia-ischemia (HI) that is
characterized by focal white and gray-matter injury.
Methods: C57Bl/6 mice at PND 5 were subjected to unilateral HI induced by left carotid artery ligation and
subsequent exposure to 10% O2 for 50 minutes, 70 minutes, or 80 minutes. At seven days post-HI, the white/gray-matter
injury was examined. The immune responses in the brain after HI were examined at different time points after HI
using RT-PCR and immunohistochemical staining.
Results: HI for 70 minutes in PND 5 mice induced local white-matter injury with focal cortical injury and hippocampal
atrophy, features that are similar to those seen in preterm brain injury in human infants. HI for 50 minutes resulted in a
small percentage of animals being injured, and HI for 80 minutes produced extensive infarction in multiple brain areas.
Various immune responses, including changes in transcription factors and cytokines that are associated with a T-helper
(Th)1/Th17-type response, an increased number of CD4+ T-cells, and elevated levels of triggering receptor expressed
on myeloid cells 2 (TREM-2) and its adaptor protein DNAX activation protein of 12 kDa (DAP12) were observed using
the HI 70 minute preterm brain injury model.
Conclusions: We have established a reproducible model of HI in PND 5 mice that produces consistent local white/
gray-matter brain damage that is relevant to preterm brain injury in human infants. This model provides a useful tool
for studying preterm brain injury. Both innate and adaptive immune responses are observed after HI, and these
show a strong pro-inflammatory Th1/Th17-type bias. Such findings provide a critical foundation for future studies
on the mechanism of preterm brain injury and suggest that blocking the Th1/Th17-type immune response might
provide neuroprotection after preterm brain injury.
Keywords: Brain injury, Preterm, Hypoxia-ischemia, Immune response
Background
Prematurity is associated with an elevated risk of suffer-
ing from brain injuries, and these brain injuries are asso-
ciated with impaired quality of life due to disorders such
as cerebral palsy and behavioral, social, attentional, and
cognitive deficits. The most common form of brain injury
in preterm infants is generally thought to consist primarily
of periventricular leukomalacia (PVL), a specific form of
cerebral white-matter injury that is often accompanied by
elements of gray-matter injury [1-3]. PVL can be either
cystic necrotic or non-cystic. The cystic necrotic form is
associated with the loss of all cellular elements, but the
non-cystic lesions are more diffuse and cell-specific. The
diffuse non-cystic lesions are the most common form of
injury seen in preterm infants at present, and these pri-
marily affect premyelinating oligodendrocytes (preOLs)
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ferentiate into mature oligodendrocytes, which results in
cerebral hypomyelination [4-6].
Hypotensive episodes and hypoxic events, inflamma-
tion and infection [7-9], and tissue hypoxia arising from
inflammation/infection are the major initiating factors of
preterm brain injury. The ischemia-reperfusion injury
process has been confirmed by the presence of infarctions
in the arterial end and border zones of the periventricular
white matter [10,11] and by the observation of pressure-
passive circulation without autoregulatory function in
newborn infants [12]. The most commonly used method
for studying hypoxia-ischemia (HI)-induced brain damage
in the neonatal brain is a rodent HI model referred to as
the Vannucci model [13]. This model is very well charac-
terized for mice and rats between postnatal day (PND) 7
and PND 10 [14-21], and adaptations in younger rodent
pups including PND 3 to 6 rats [22] and PND 6 to 7 mice
[23,24] have also been developed. The periventricular
white matter in humans is highly susceptible to HI at ges-
tational weeks 24 to 32 due to its high proportion of pre-
OLs, and it is known that the number of preOLs is
highest at PND 2 to 5 in rodents and that this number
quickly declines after this developmental stage [25]. By
PND 6–7, extensive oligodendrocyte (OL) maturation oc-
curs in rodents and this coincides with the onset of early
myelination [26]. Thus, white-matter vulnerability in the
rodent at PND 2 to 5 would correspond to that in preterm
human infants.
HI-induced injury to the immature brain has been found
to induce the expression of various genes related to im-
mune responses and inflammation, including macrophage
and microglia-related genes, T-lymphocyte–related genes,
and cytokines [27]. In addition, inflammatory mediators
have been suggested to contribute to injury after HI in the
immature brain [28] at a stage corresponding to human
term and near-term infants. The immune system develops
rapidly immediately after birth. For example, mice are not
able to produce detectable levels of humoral antibodies in
response to antigen until after one week of age, and the
antigen-presenting dendritic cells do not reach normal
levels as it is in adult rodent until one week after birth [29].
This indicates that the inflammatory response is likely to
be very different during the first days after birth compared
to one week later, and the differences are even more pro-
nounced compared to older rodents [29]. However, the in-
flammatory and immune responses after HI brain injury in
mice younger than PND 7 have not been characterized.
The first aim of this study was to use the Vannucci model
to find the duration of hypoxia that causes focal white/
gray-matter injury in PND 5 mice, a developmental age in
mice that corresponds to the preterm human infant. The
second aim was to characterize the immune/inflammatory
response after HI in this preterm injury model.
Methods
Animals
Pregnant C57BL/6 J mice were purchased from Charles
River Laboratories (Sulzfeld, Germany) and these gave
birth in the animal facility at the University of Gothenburg
(Experimental Biomedicine, University of Gothenburg).
The day of birth was defined as PND 1. Mice were housed
with a 12-hour light/dark cycle, and free access to a
standard laboratory chow diet (B&K, Solna, Sweden)
and drinking water was provided. All animal experi-
ments were approved by the Animal Ethical Committee
of Gothenburg (Number 51/2012, 5/2013).
Hypoxia-ischemia procedure
At PND 5, mice of both sexes were subjected to HI insult
according to a method described previously with some
modifications [13]. Briefly, mice were anesthetized with
isoflurane (5.0% for induction and 1.5 to 3.0% for mainten-
ance) in a 1:1 mixture of nitrous oxide and oxygen. The left
common carotid artery was ligated, and the mice were
returned to their cage and allowed to recover for one
hour. The mice were then placed in an incubator per-
fused with a humidified gas mixture (10 ± 0.01% oxygen
in nitrogen) at 36°C for 50 minutes, 70 minutes, or 80
minutes. After HI, the pups were returned to their dam
until being killed. The combination of artery ligation
and hypoxia resulted in injury only in the hemisphere
ipsilateral to the artery ligation (the left hemisphere),
while no injury was produced in the contralateral hemi-
sphere (the right hemisphere). PND 9 mice were sub-
jected to hypoxia for 50 minutes to produce a
comparable degree of injury in the hippocampus as seen
after 70 minutes HI in the PND 5 mice [30].
Assessment of brain damage
Mice were deeply anesthetized and perfused intracardi-
ally with saline and 5% buffered formaldehyde (Histofix;
Histolab Products AB, Gothenburg, Sweden). The brains
were dissected, paraffin-embedded, and cut into 10-μm
coronal sections throughout the whole brain. Immuno-
histochemical staining for microtubule-associated pro-
tein 2 (MAP-2) and myelin basic protein (MBP) was
performed on every 50th section.
The extent of white- and gray-matter injury was ana-
lyzed by quantitative measurements of the injury area
(at 4× magnification) using Micro Image version 4.0
(Micro-macro AB, Gothenburg, Sweden). The MAP-2-
positive or MBP-positive area (remaining tissue) was
measured in each hemisphere as previously described
[31,32], and total tissue loss was calculated as:
Contralateral hemisphere–ipsilateral hemisphere ðÞ =
Contralateral hemisphereÞ 100%
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all other staining. Thionin/acid fuchsin staining was per-
formed as described previously [33]. Briefly, the sections
were dipped in 1% thionin/toluidin solution, dipped into
acid fuchsin solution, and dehydrated in a gradient of
ethanol before mounting.
Immunohistochemical staining
After antigen recovery and blocking, the following pri-
mary antibodies were used: mouse anti-MAP-2 (clone
HM-2, Sigma-Aldrich, Stockholm, Sweden), mouse anti-
MBP (SMI94, Covance, NJ, USA), goat anti-triggering
receptor expressed on myeloid cells-2 (TREM-2, clone
G-18, Santa Cruz Biotechnology, Santa Cruz, CA, USA),
rabbit anti-ionized calcium binding-adapter molecule 1
(Iba-1, Wako Chemicals, Richmond, VA, USA), and mouse
anti-cluster of differentiation 4 (CD4, Vector Laboratories,
Burlingame, CA, USA). After incubation with the appropri-
ate biotinylated secondary antibody (Vector Laboratories,
Burlingame, CA, USA), visualization was performed using
Vectastain ABC Elite with 3,3′-diaminobenzidine (DAB)
enhanced with ammonium nickel sulfate, beta-D glucose,
ammonium chloride, and beta-glucose oxidase (all from
Sigma-Aldrich, Stockholm, Sweden).
For fluorescent triple staining, the sections were incu-
bated with goat anti-TREM-2, mouse anti-DNAX acti-
vating protein 12 antibody (DAP12, clone B-2, Santa
Cruz Biotechnology, Santa Cruz, CA, USA) and rabbit
anti-Iba-1. The sections were then incubated with the
appropriate Alexa Fluor 594 donkey-anti-rabbit or Alexa
Fluor 488 donkey-anti-mouse (Molecular Probes, Leiden,
Netherlands) secondary antibody in PBS, and a coverslip
was mounted using ProLong Gold antifade reagent with
4,6-diamidino-2-phenylindole (DAPI) (Life Technologies,
Carlsbad, CA, USA).
RT-PCR
Changes in cytokine gene expression in the brain at 6
hours, 24 hours, or 7 days after HI in PND 5 and control
mice were analyzed by RT-PCR. After a brief intracardial
perfusion with saline, the brains were rapidly dissected,
divided into ipsilateral and contralateral hemispheres,
snap frozen, and stored at −80°C until use.
The brain tissue was homogenized with Qiazol lysis
reagent homogenizer (Qiagen, Sollentuna, Sweden), and
total RNA was extracted using the RNeasy Lipid Tissue
Mini Kit (Qiagen, Sollentuna, Sweden). RNA was mea-
sured with a spectrophotometer at 260 nm absorbance.
cDNA was synthesized using a QuantiTect Reverse Tran-
scription Kit (Qiagen, Sollentuna, Sweden) following
the manufacturer’s instructions, and each sample was
run in duplicate. The following primers were used: RAR-
related orphan receptor gamma (RORγt, QT00197722),
T-bet (QT00129822), GATA binding protein 3 (GATA3,
QT00170828), forkhead box P3 (Foxp3, QT00138369),
IL-4 (QT00160678), IL-5 (QT00099715), IL-6 (QT00098875),
IL-10 (QT00106169), IL-12a (p35) (QT01048334), IL-13
(QT02423449), IL-17α (QT00103278), IL-21 (QT01758036),
IL-22 (QT00128324), IL-23a (QT01663613), transform-
ing growth factor beta (TGF-β, QT01038821), IFN-γ
(QT00145250), B- and T-lymphocyte attenuator (BTLA, QT0
0117635), CXCR5 (QT00253449), CXCL13 (QT00107919),
inducible T-cell co-stimulator (ICOS, QT02253552),
and 18S ribosomal RNA (QT01036875) (all from Qiagen,
Sollentuna, Sweden). Melting curve analysis was per-
formed to ensure that only one PCR product had been
produced. A standard curve was generated for quantifica-
tion and for estimating amplification efficiency using in-
creasing concentrations of cDNA, and the amplification
transcripts were quantified with the relative standard
curve and normalized to the 18S ribosomal RNA refer-
ence gene.
Statistics
The Statistical Package for the Social Sciences (SPSS
Inc., Chicago, IL, USA) v19.0 software package was used
for all analyses. Comparisons between groups were per-
formed by Student’s t-test, and data with unequal vari-
ance were compared with the Mann-Whitney U-test.
Analysis of variance followed by the LSD post-hoc test
was used for comparison of data from more than two
groups. P < 0.05 was considered statistically significant.
Results
White/gray-matter injury after HI in PND 5 mice
To determine the duration of hypoxia in PND 5 mice
that produces mild and focal white/gray-matter injury,
we tested hypoxia durations of 50 minutes, 70 minutes,
and 80 minutes in combination with left carotid artery
ligation using the Vannucci model. Mice were killed
three or seven days after HI to evaluate the extent of
brain injury. All pups tolerated HI well and none of the
pups died during or soon after the HI insult. Thionin/
acid fuchsin staining showed that after 50 minutes of
hypoxia only 3/12 (25%) of the mice had suffered visible
brain injury (Table 1). The injury was mostly found in
the hippocampus and was characterized by loss of neu-
rons in the CA1 to CA3 areas in the cerebral hemi-
sphere ipsilateral to the carotid ligation (Table 1,
Figure 1B, arrows in Figure 2D and 2H). No injury was
found in the contralateral hemisphere (Figure 1A and
Figure 2C and 2E). Only 2/12 (17%) of the mice dis-
played mild local white-matter tissue disruption in the
ipsilateral hemisphere (Figure 2D and 2G) in comparison
to the contralateral hemisphere (Figure 1A and Figure 2C
and 2F).
When the duration of hypoxia was extended to 70 minutes,
13/14 (93%) of the mice were injured (Table 1). The
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Hypoxia time Percent of injured mice CX injury Hipp. injury Subcortical WM injury
50 minutes 25% No Loss of granular cells in the CA areas Localized and diffuse
70 minutes 93% selective neuronal injury Tissue structure disruptions WM diffuse injury and tissue
structure disruptions
80 minutes 88% Infarction Infarction Infarction
Abbreviations: CA cornu ammonis, CX cortex HI hypoxia-ischemia, Hipp hippocampus, PND postnatal day, WM white matter.
Figure 1 Representative photomicrographs of thionin/acid fuchsin-stained brain sections. It shows different degrees of injury in the
ipsilateral hemisphere at 3 days after HI with 50 minutes (A, B, n = 12), 70 minutes (C, D, n = 14), or 80 minutes (E, F, n = 16) of hypoxia. Arrows
in (D) indicate focal subcortical white-matter injury in the ipsilateral hemisphere of the HI 70-minute mouse brain.
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ation with focal white-matter injury (arrows in Figure 1D,
and Figure 3D) as well as small areas of focal cortical injury
in the ipsilateral hemisphere (star and arrows in Figure 3E).
Only 1/14 (7.1%) of the mice showed cortical infarction.
Notably, the subcortical white matter area in the PND 5
mice showed significantly greater vulnerability compared
with the surrounding striatum and cortex in the same area
(arrows in Figure 1D and Figure 3D), which was not seen
in PND 9 HI mice (Figure 3F and 3G).
In pups subjected to 80 minutes of HI, 14/16 (88%) of
the mice were injured and 6/16 (37.5%) of the mice dis-
played extensive infarction in the cortex, hippocampus,
white matter, and thalamus in the ipsilateral hemisphere
(Table 1 and Figure 1F). No injury was observed in the
contralateral hemisphere (Figure 1E).
To evaluate the effect of HI on myelination and gray-
matter injury, MBP and MAP-2 immunostaining was
performed at PND 12 (7 days after HI), which is the age
when myelin begins to be detectable in mice [34]. After
Figure 2 Brain injury after 50-minute hypoxia-ischemia (HI) insult. Dot graphs show the volume difference between the ipsilateral and
contralateral hemispheres in gray matter (A) and white matter (B) at 7 days after 50-minute HI in PND 5 mice (n = 16). Abbreviations: Contra:
contralateral hemisphere; Ipsi: ipsilateral hemisphere. *P < 0.05 by Student’s unpaired t-test. Data are presented as mean ± SEM. (C-H) Representative
photomicrographs of thionin/acid fuchsin-stained sections show diffuse injury in the subcortical white matter area (D and G) and focal granular layer
loss in the hippocampus CA3 area (D and H) that is only observed in the ipsilateral hemisphere and not in the contralateral hemisphere ( C ,E ,a n dF )
at 3 days after HI in PND 5 mice. Arrows in (D) indicate focal injury in the CA1 granular layer of the hippocampus in the ipsilateral hemisphere.
Figure 3 Brain injury after 70-minute hypoxia-ischemia (HI) insult. Dot graphs showing the volume difference between the contralateral and
ipsilateral hemispheres in gray matter (A) and white matter (B) at 7 days after 70-minute HI in PND 5 mice (n = 13). *P < 0.05, ***P < 0.001 using
Student’s unpaired t-test. Data are presented as mean ± SEM. Abbreviations: Contra: contralateral hemisphere; Ipsi: ipsilateral hemisphere. (C) The
simple linear regression analysis shows the linear correlation between the two evaluation methods. (D-G) Representative photomicrographs of
H&E-stained sections show focal injury in the subcortical white matter in the ipsilateral hemispheres at 3 days after HI in PND 5 mice (D and E)
but not in PND 9 mice (F and G) with a similar degree of injury. Arrows in (D) show subcortical white-matter injury. Arrows and star in (E) show
focal gray-matter injury in the ipsilateral hemisphere of the PND 5 HI mouse brain.
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matter volume (Figure 2A) in the ipsilateral hemisphere
compared with the contralateral hemisphere. There was
no significant difference observed in terms of myelination
(Figure 2B) between the two brain hemispheres.
In pups exposed to 70 minutes of HI, both the gray-
matter volume (Figure 3A) and the white-matter volume
(Figure 3B) in the ipsilateral hemisphere were signifi-
cantly reduced compared with the contralateral hemi-
sphere at 7 days post-HI (PND 12). A simple linear
regression analysis comparing the total brain tissue loss
(volume) with the tissue loss in one representative brain
section (area) from the hippocampus level showed a sig-
nificant positive linear correlation between the two
methods (Figure 3C, P <0.001, R
2=0.9686).
At 7 days after HI (PND 12) when myelination was
formed and was visible by MBP staining, the subcor-
tical white matter displayed abnormal myelin structure
(Figure 4B and 4D) in the ipsilateral hemisphere com-
pared to the normal morphology of the subcortical
white matter in the contralateral hemisphere (Figure 4A
and 4C). Quantification of MBP-positive immunostain-
ing in the subcortical white matter area demonstrated
that the subcortical white matter volume loss in the ip-
silateral hemisphere for the 70 minutes HI group was
14.0 ±4.2%, whereas no white matter loss was seen in
the 50 minutes HI group. No gender differences were
found for any of the hypoxia durations in this study.
We found that 70 minutes of HI results in focal diffuse
white-matter injury combined with hippocampus injury,
small areas of focal cortical injury, and a low frequency
of cortical infarction. We concluded, therefore, that
70 minutes is the optimal duration of HI to induce brain
injuries in PND 5 mice, and this model was used in the
subsequent characterization of the inflammatory/im-
mune responses after HI insults.
Increased DAP12 and TREM-2 expression after HI
Triggering receptors expressed on myeloid cells (TREMs)
are innate immune receptors that play an important role
in fine-tuning the inflammatory response by altering the
innate immune response. DNAX activation protein 12
(DAP12) is a transmembrane signaling adaptor protein
that forms a molecular complex with TREM-2. TREM-2
is expressed on the cell membrane of monocyte-derived
dendritic cells, osteoclasts, and microglia. Activation of
DAP12 and TREM-2 plays an important role in demyelin-
ation disease in humans, and this led us to examine the
possible role of this pathway in preterm brain injury,
which is characterized by extensive white-matter injury.
Brain sections from the hippocampal level were ana-
lyzed by immunohistochemistry at 24 hours, 3 days, and
7 days after 70-minute HI at PND 5. TREM-2 expression
in the brain was increased in the ipsilateral hemisphere
after HI with maximum expression seen at 24 hours
after HI (Figure 5A and 5B). The increased TREM-2 ex-
pression at 24 hours after HI was mostly observed in the
ipsilateral hippocampus, subcortical white matter, and
white matter/thalamus (Figure 5B, 5C, and 5D). TREM-
2 expression was also found in the meninges and the
choroid plexus structure in the lateral and third ventricle
(Figure 5E and 5F). The TREM-2
+ cells were located
Figure 4 Impaired myelin structure at 7 days after 70-minute hypoxia-ischemia (HI). Representative photomicrographs of myelin basic
protein (MBP)-stained brain sections at the hippocampal level show impaired myelin development and disrupted myelin structure in the subcortical
white matter of the ipsilateral hemisphere (B and D) compared with the contralateral hemisphere (A and C).
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the blood vessels (Figure 5D). The triple fluorescent
staining of TREM-2 with microglia marker Iba-1 and
DAPI nuclear staining indicated that some TREM-2
+
cells are microglia (Figure 5G-J). The TREM-2 expres-
sion in the lateral ventricles displayed more TREM-2
+
staining in the ipsilateral lateral ventricle compared to
the contralateral ventricle, and the expression was higher
in the choroid plexus of the third ventricle at 24 hours
after HI compared to age-matched undamaged controls.
However, the TREM-2
+ staining in the meninges did not
differ between the two hemispheres.
The DAP12 expression in the brain after 70 minutes HI
at PND 5 was evaluated by immunofluorescence staining at
24 hours, 3 days, and 7 days after HI. The expression of
DAP12 was found in the injured area in the subcortical
white matter area, the hippocampus, the periventricular
area, and the meningeal areas in the ipsilateral hemisphere.
Triple immunofluorescence staining for DAP12, the micro-
glia marker Iba-1 and DAPI showed that DAP12 and Iba-1
double-positive cells were found in the ipsilateral periven-
tricular area at 24 hours after HI (Figure 6A-6D). Iba-1 and
DAP12 double-positive cells were also detected close to
blood vessels in the ipsilateral hippocampus (Figure 6E-6H)
and in the meningeal area at three days after HI.
The immune cell response after HI in PND 5 mice
To examine the possible infiltration of immune cells into
the brain after HI, we used immunohistochemical staining
with an antibody against CD4. Indeed, the number of
CD4
+ cells in the brain increased at 24 hours and 7 days
after HI compared with age-matched undamaged control
mice (Figure 7A). Most of the CD4
+ cells were seen in
blood vessels, and only a few were seen in the brain tissue
(Figure 7C and 7D). Because it is one of the most import-
ant organs of the immune system, spleen weight was mea-
sured at 24 hours, 3 days, and 7 days after HI and in
undamaged control mice. A significant increase in spleen
weight was seen at 24 hours and 3 days, but not at 7 days,
after HI compared to controls (Figure 7B) suggesting
that an HI-induced global inflammatory response might
increase the trafficking of immune cells, including CD4
+
T-cells, into the injured brain during the early phase of
inflammation.
Different canonical types of cytokine responses after HI in
PND 5 mice
To further evaluate the inflammatory/immune response
in the HI-induced preterm brain injury model described
above, brains were harvested at 6 hours, 24 hours, and 7
days after HI and from uninjured age-matched control
mice. The expression of several cytokine mRNAs was al-
tered in the ipsilateral brain hemisphere after HI (Figure 8)
but there were no significant changes in the contralateral
brain hemispheres after HI.
We first investigated whether the transcription of
immunity-related genes, including those related to CD4+
T-helper (Th) cells, were affected by HI. At six hours after
(See figure on previous page.)
Figure 5 TREM-2 expression after 70-minute hypoxia-ischemia (HI) insult. Representative photomicrographs show TREM-2
+ immunohistochemical
staining in the contralateral (A) and ipsilateral (B) hemispheres at 24 hours after HI. (C and D) TREM-2
+ cells in the hippocampus in the brain parenchyma
(C) and blood vessels (D). (E) TREM-2
+ cells in the choroid plexus at 24 hours after HI. (F) A higher magnification of TREM-2
+ staining.
(G-L) TREM-2 staining (H) co-localizes (G, arrows) with microglia marker Iba-1 (I) in the choroid plexus at 24 hours after HI. (J) DAPI nuclear staining.
Figure 6 DAP12 expression after a 70-minute hypoxia-ischemia (HI) insult. Representative photomicrographs show expression of DAP12
(green) and its co-localization with the microglia marker Iba-1 (red) after HI. DAP12 and Iba-1 double-positive cells were found in the dentate
gyrus (A-D) at 24 hours after HI, and in the proximity of blood vessels in the CA1 area of the hippocampus (E-H) at 3 days after HI.
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for the Th type 1 (Th1) cell transcription factor T-bet
and the Th1 cell-promoting cytokine IL-12a in the
brain (Figure 8). IFN-γ - the signature cytokine secreted
from Th1 cells - was not detectable in the brain after
HI in PND 5 mice.
The Th2 transcription factor GATA3 was not affected
by HI, but the IL-4 cytokine, which promotes the differen-
tiation of Th2 cells, was significantly down-regulated at 6
hours and 24 hours after HI. IL-13, a cytokine produced
mainly by Th2 cells, was significantly up-regulated at 6
hours after HI, but no changes were observed for IL-5
(Figure 8).
For the Th17-type cytokine response, the transcription
factor RORγt was significantly increased at 7 days after
HI. The expression of the Th17-promoting cytokine IL-6
was significantly increased at 6 hours and 24 hours after
HI. Cytokine IL-22, which is secreted from Th17 cells,
was significantly increased at 6 hours after HI. IL-17A
was not detected in the brain in the normal control
animals at any of the time points analyzed.
For the T-regulatory (Treg) type of response, the ex-
pression of the Treg transcription factor Foxp3 was sig-
nificantly decreased at 6 hours and 24 hours after HI.
However, there was no change in levels of the Treg-
promoting cytokine TGF-β or the Treg-secreted cytokine
IL-10.
Discussion
We have established a novel PND 5 mouse preterm
brain injury model to show that both the innate and
adaptive immune responses are activated after HI at this
age. This model has allowed us for the first time to
examine the responses of different subsets of Th cells in
a neonatal HI model, and we found that HI induced a
primarily Th1/Th17-type immune response in the neo-
natal mice.
Fifty minutes of HI produced mild injury localized in
the white and gray matter, and this degree of injury is
similar to that previously reported in PND 6 HI mice
[23]. However, only 25% of the mice were damaged and
most of the pups did not display any signs of injury. Fur-
thermore, no significant differences were seen in the
white-matter volume between the ipsilateral and contra-
lateral hemispheres, and this limits the usefulness of the
50-minute HI exposure in neuroprotection studies. When
the HI duration was extended to 80 minutes, the injury in
the ipsilateral hemisphere was very extensive and included
widely distributed infarction of the hippocampus, cortex,
and thalamus that is rarely seen in preterm infants.
The model using 70 minutes of HI produced diffuse
white-matter injury combined with focal neuronal loss
in the cerebral cortex and hippocampus injury (Table 1).
Indeed, at 7 days after HI (PND 12), the time when mye-
lination becomes detectable in mice, we found impaired
Figure 7 CD4
+ T-cells in the mouse brain after hypoxia-ischemia (HI) in postnatal day (PND) 5 mice. The total number of CD4
+ cells in
blood vessels and in tissue from both of the brain hemispheres from a section at the hippocampus level (A) and spleen weight (B) in uninjured
control (Cont) mice versus HI mice at different time points after HI. *P < 0.05, **P < 0.01, ***P < 0.001 using Student’s unpaired t-test. Data are
presented as mean ± SEM. (C and D) Representative immunostainings show CD4
+ cells in blood vessels in the ipsilateral subcortical white matter
(C) and ipsilateral hippocampus CA1 area (D) at seven days post-HI.
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lateral hemisphere (Figure 4B and 4D). Seventy minutes
of HI significantly reduced both white- and gray-matter
volume in 93% of the pups (Figure 3A and B), and this
makes the model reliable and suitable for neuroprotec-
tion studies. Interestingly, we found that the degree of
white-matter vulnerability after 70 minutes of HI at
PND 5 (Figure 3D and 3E) was more obvious compared
to that seen at PND 9 in mice (Figure 3F and 3G). This
observation further confirms that PND 5 is within the
time window when the white matter in the brain is more
vulnerable to injury [35].
TREM-2 is expressed on the cell membrane of
monocyte-derived dendritic cells, osteoclasts, and micro-
glia and is associated with the signaling molecule DAP12
[36,37]. DAP12 in turn plays a signal transduction role
in dendritic cells and macrophages and is considered to
be both pro- and anti-inflammatory [38]. Apart from
their function in the inflammatory response, DAP12 and
TREM-2 clearly play an important role in white-matter
Figure 8 The canonical types of cytokine and transcription factor gene expression in the brain after hypoxia-ischemia (HI). *P < 0.05,
**P < 0.01, ***P < 0.001 using Student’s unpaired t-test. Data are presented as mean ± SEM. N = 5 to 8/group. White bars: undamaged controls;
Black bars: post-HI ipsilateral hemisphere. Abbreviations: Th: T-helper cells; Treg: T-regulatory cells.
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TREM-2 and DAP12 cause sclerotic lesions in the white
matter of the central nervous system (CNS) in human
polycystic lipomembranous osteodysplasia with scleros-
ing leukoencephalopathy (PLOSL)/Nasu-Hakola disease
[39,40] and cause hypomyelinosis in mice [41]. DAP12
+
and TREM-2
+ microglia/macrophages surround myeli-
nating oligodendrocytes at PND 10 [42]. TREM-2 is
expressed by microglia in the CNS both during normal
development in mice [43] and in experimental auto-
immune encephalomyelitis (EAE) - a mouse model of
multiple sclerosis (a white-matter disease) [44,45]. Block-
age of TREM-2 signaling using an anti-TREM-2 anti-
body increases the severity and progression of EAE [44].
We found increased expression of TREM-2 and
DAP12 in the brain after HI with maximum expression
at 24 hours after HI in the injured areas of the hippo-
campus and the white matter. DAP12 was co-expressed
with microglia in the brain parenchyma, and this agrees
with previous findings in the normal neonatal mouse
brain [43] and in the rodent model of HI that is more
representative of the type of brain injury seen in full-
term infants [27]. The expression of DAP12 is found not
only in injured areas but also in the meninges. Together
with the finding that TREM-2 is also expressed in the
choroid plexus and along the blood vessels, this indicates
that the TREM and DAP12 pathway might serve as a
sensor/communicator at the interface between the per-
iphery and the CNS and might participate in the devel-
opment of white-matter injury in preterm infants.
The accumulation of TREM-2, DAP12, and CD4
+ T-
cells in the meninges and choroid plexus and adherence
to blood vessels might also have implications for the sta-
tus of cerebrovascular reactivity. Similarly, another recent
report showed that TREM-2 was expressed by some
microglia/macrophages inside and around the blood ves-
sels of the hippocampal fissure in PND 1 mouse brains,
and such expression diminished with age [43]. The vascu-
lature of the blood-brain barrier (BBB) protects the CNS
from the systemic circulation by restricting entry of un-
wanted molecules and immune cells into the brain. Re-
ports have shown that TREM-2 knockout mice have
reduced invasion of CD3
+ T-cells [46] through yet un-
known mechanisms. Together with our finding that
TREM-2 is located close to the blood vessels in the chor-
oid plexus, this indicates that TREM-2 might actively par-
ticipate in the invasion of peripheral T-cells into the brain
through the choroid plexus and BBB by either modulating
the BBB permeability in the brain or directly regulating
the blood flow.
T-cells have been observed infiltrating the brain in the
infarction area in animal models of stroke, and it is now
widely accepted that T-cells play a role in both ischemic
brain injury (stroke) and white-matter injury (multiple
sclerosis) in both adult animal models and humans
[47,48]. For example, T-cell-deficient mice exhibit sig-
nificant reductions in infarct volume [49,50] in rodent
models of HI brain injury. T-cells and other peripheral
immune cells were found to infiltrate into the neonatal
rat brain and to remain there for hours to months fol-
lowing HI [51-53].
In this study, we found that there were low, yet signifi-
cantly increased, numbers of CD4
+ cells in the brain
after HI at PND 5 and that this was accompanied by
changes in spleen weight, one of the most important or-
gans in the immune system. At the time points exam-
ined in the present study, which are all relatively early
for the adaptive immune response, the CD4
+ T-cells are
mostly located adhered to the blood vessels in the brain
instead of in the brain parenchyma. This might well in-
dicate that CD4
+ cells are beginning to infiltrate into the
brain at a relatively early stage in the adaptive immune
response in addition to other cell types that are also in-
volved in the early immune response in the brain.
Mammalian immune responses are often grouped into
type 1 and type 2 responses [54]. These responses differ
broadly in their mechanisms of induction as well as their
innate cell types, cytokines, effector molecules, and Th
types. The classical type 1 and type 2 responses are me-
diated by TCRαβ CD4
+ Th cells and are thus generally
referred to as Th1 and Th2 responses, respectively. It is
now clear that many innate cell types such as γδ T-cells
and innate lymphoid cells (ILCs) broadly parallel the
known CD4
+ Th cell subsets in terms of their signature
cytokine secretion profiles. An overlapping series of
transcription factors is also used to drive the differenti-
ation of the various ILC and Th cell subsets. The results
of our experiments show that HI leads to an imbalance
between Th1/Th17-type responses and Th2/Treg-type
responses, and these differences might be due to the re-
cruitment and proliferation of different innate-type im-
mune cells.
Type 1 immune responses are usually pro-inflammatory
and are mediated by the type 1 cytokines such as IFN-γ,
TNF-α, IL-6, and IL-17 [55]. In contrast, type 2 responses
have immune-modulating functions and mediate allergic
inflammatory diseases such as asthma, allergic rhinitis,
and atopic dermatitis. Th2 cells regulate type 2 responses
through the secretion of various type 2 cytokines, includ-
ing IL-4, IL-5, IL-9, and IL-13. For many years, neonates
have been considered to be immune deficient. It is now
clear, however, that the newborn is capable of raising
an immune response. Neonatal mice that have primary
immune responses to certain foreign antigens normally
mount Th2-type-dominant secondary responses when
re-exposed to the same antigens. However, under certain
pathogenic infections or after immunization with certain
adjuvants that promote strong Th1-cell responses, such as
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neonates develop Th1-type responses that often induce
the onset of diseases [54,56,57]. In HI-induced brain injury
in neonatal mice, we observed an increased expression of
Th1/Th17-related transcription factors that may reflect a
dominant Th1-type response that could contribute to the
brain injury. Indeed, high expression of Th1 and Th17-
type cytokines has been found in PVL patients [58-60],
and inhibition of Th17-type cytokines reduces brain injury
in a neonatal mouse model [61]. Moreover, Th17 lympho-
cytes traffic to the CNS [62] and participate in the patho-
genesis of CNS inflammatory demyelination disease [63].
These indicate that different types of immune responses
might play different roles in preterm brain injury.
In this study, we examined different types of immune
responses by examining the stimulatory cytokines that are
present in the microenvironment during activation, tran-
scription factors that prime naive precursor cells for differ-
entiation, and the signature cytokine profiles for each type
of response. We observed significantly increased levels of
Th1-related (T-bet, IL-12a) and Th17-related (RORγt, IL-
6, IL-23, and IL-22) transcription factors and cytokines
after HI, and most Th2/Treg-related transcription factors
and cytokines were either decreased (IL-4) or unchanged
(GATA3, IL-5, Foxp3, TGFβ, and IL-10). Notably, the sig-
nature cytokine for Th17-related response (IL-17A) was
not detectable in the neonatal mouse brain in the current
study. We carefully analyzed the IL-17A expression in
normal neonatal mice, but could not detect any mRNA
under our experimental conditions. However, analysis of
IL-17A expression in the present study focused on the
early time points within 7 days post-HI when the adaptive
immune responses are not initiated, and the early Th1/
Th17-type response in the brain after HI might be due to
innate-type cell types, for example, γδ T-cells and ILCs.
Possibly, IL-17A could be expressed at later time points
after HI when massive infiltration of T-cells into the CNS
starts, since unlike its other analogs (that is, IL-17F),
IL-17A is produced mainly in T-cells [64]. For the Th2-
type response, we did find significantly increased levels
of the Th2-type cytokine IL-13 in the brain at 6 hours
after HI. IL-13 is a mediator of allergic inflammation
and disease, and in the brain IL-13 has been found to
induce oxidative stress and contribute to the death of
activated microglia [65,66]. In general, it seems that the
physiological Th2/Treg-type bias is lost in preterm
brain injury after HI in mice and that the balance is in-
stead skewed towards a type 1 (Th1/Th17) immune re-
sponse (Figure 8).
Altogether, these results indicate that HI triggers a ro-
bust immune response in the brain that is characterized
by an imbalance between Th1/Th17- and Th2/Treg-type
responses. This imbalance occurs early in the immune
response and is probably caused by an innate type of
response as indicated by the increased yet low number
of CD4
+ cells mostly located in the blood vessels.
Conclusions
Cerebral palsy is the most common severe neurological
disability in children worldwide and is a heavy burden on
those afflicted, their families, and society. Preterm brain in-
jury is a major cause of cerebral palsy and there are cur-
rently no neuroprotective therapies available for premature
infants. Inflammation plays a critical role in the develop-
ment of preterm brain injury, and T-cells have been
suggested to play essential roles in the response to is-
chemic brain injury [47,48,51,52]. Therefore, targeting
the inflammation-specific immune cell population/path-
ways [9,67,68] might represent a new hope for the preven-
tion and treatment of preterm brain injury. In the present
study, we have established a reproducible PND 5 mouse
model of HI-induced preterm brain injury, and we have
further characterized the innate and adaptive immune re-
sponses and found the involvement of a Th1/Th17-type
immune response after HI-induced preterm brain injury in
the established model. This model will provide a powerful
tool to study preterm brain injury mechanisms and to in-
vestigate possible neuroprotectants with the goal of discov-
ering treatment strategies for preterm brain injury. The
immune response observed in this model will provide a
solid foundation for continued studies of the contribution
of the neonatal immune system to preterm brain injury
and provide evidence for neuroprotection by targeting spe-
cific inflammatory cascades after preterm brain injury.
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